Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$395,640
-$220,424 QoQ
Shares Held
1,413
-38.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#631
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $36,872,593 across 15 Diagnostics & Research names. LH ranks #12 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
48,390 | $24,260,810 | |
| 2 | DHR |
Danaher Corp /De/
|
24,345 | $4,637,235 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,497 | $1,314,520 | |
| 4 | BLLN |
BillionToOne, Inc.
|
9,129 | $1,095,297 | |
| 5 | ILMN |
Illumina, Inc.
|
4,435 | $779,806 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,637 | $770,862 | |
| 7 | NTRA |
Natera, Inc.
|
2,799 | $759,788 | |
| 8 | WAT |
Waters Corp /De/
|
1,613 | $604,939 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $395,640 | 1,413 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $616,064 | 2,309 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $551,434 | 2,198 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $685,212 | 2,387 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $537,095 | 2,046 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $475,255 | 2,042 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $629,712 | 2,746 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,889,969 | 8,457 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,859,063 | 9,135 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||